Who
Nailesh Bhatt
Director
Company insider
Files Form 4 as: Director, Hyperliquid Strategies; Director, Sonnet BioTherapeutics Holdings.
In numbers
- Trades disclosed
- 16
- Buys
- 1
- Sells
- 0
- Bought
- $5,750
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Apr 2020
- Last trade
- 1 Oct 2026
- Last filed
- 15 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 15 Oct 2026 | PURR Hyperliquid StrategiesDigital Asset Treasuries | SEC FORM 4 Code A | —2,037 | filing |
| 1 Jul 2026filed 6 Jul 2026 | PURR Hyperliquid StrategiesDigital Asset Treasuries | SEC FORM 4 Code A | —1,588 | filing |
| 1 Jul 2026filed 6 Jul 2026 | PURR Hyperliquid StrategiesDigital Asset Treasuries | SEC FORM 4 Code A | —1,588 | filing |
| 1 Apr 2026filed 2 Apr 2026 | PURR Hyperliquid StrategiesDigital Asset Treasuries | SEC FORM 4 Code A | —2,455 at $0.00 | filing |
| 1 Apr 2026filed 2 Apr 2026 | PURR Hyperliquid StrategiesDigital Asset Treasuries | SEC FORM 4 Code A | —2,455 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | PURR Hyperliquid StrategiesDigital Asset Treasuries | SEC FORM 4 Code A | —40,789 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | PURR Hyperliquid StrategiesDigital Asset Treasuries | SEC FORM 4 Code A | —40,789 at $0.00 | filing |
| 2 Dec 2025filed 12 Dec 2025 | PURR Hyperliquid StrategiesDigital Asset Treasuries | SEC FORM 4 Code J | —2,082 | filing |
| 2 Dec 2025filed 3 Dec 2025 | Sonnet BioTherapeutics Holdings | SEC FORM 4 Code D | —10,547 | filing |
| 11 Jul 2025filed 15 Jul 2025 | Sonnet BioTherapeutics Holdings | SEC FORM 4 Code A | —10,000 | filing |
| 11 Dec 2023filed 5 Dec 2024 | Sonnet BioTherapeutics Holdings | SEC FORM 4 Code A | —373 | filing |
| 17 May 2023filed 18 May 2023 | Sonnet BioTherapeutics Holdings | SEC FORM 4 Bought | $5,75025,000 at $0.23 | filing |
| 14 Dec 2022filed 22 Dec 2022 | Sonnet BioTherapeutics Holdings | SEC FORM 4 Code A | —3,770 | filing |
| 15 Dec 2021filed 8 Apr 2022 | Sonnet BioTherapeutics Holdings | SEC FORM 4 Code A | —14,152 | filing |
| 2 Jul 2020filed 2 Jul 2020 | Sonnet BioTherapeutics Holdings | SEC FORM 4 Code A | —8,005 at $0.00 | filing |
| 1 Apr 2020filed 3 Apr 2020 | Sonnet BioTherapeutics Holdings | SEC FORM 4 Code A | —5,328 | filing |
News
No headline names them, or the companies they trade most, lately.